Reconsidering sore throats. Part I: Problems with current clinical practice.
OBJECTIVE
To provide evidence-based answers to clinical questions posed by family physicians about Group A streptococcus pharyngitis and to further understanding of why management is controversial.


METHODS
Evidence from randomized trials was not found for most questions. The most critical information came from high-quality community prevalence studies and criterion standard studies of physician clinical judgement.


RESULTS
Expert recommendations for physician management are not likely to help prevent rheumatic fever, as most people with sore throats do not seek medical care. Current clinical practices result in overuse of antibiotics because accuracy of clinical judgment is limited.


CONCLUSIONS
Costs associated with visits for upper respiratory infections as well as increasing antibiotic resistance necessitate reconsidering the current clinical approach. An alternative management strategy is presented in part 2.
McIsaac
W J
WJ
Institute for Clinical Evaluative Sciences, North York, Ont. w.mcisaac@utoronto.ca
Goel
V
V
Slaughter
P M
PM
Parsons
G W
GW
Woolnough
K V
KV
Weir
P T
PT
Ennet
J R
JR
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D019317:Evidence-Based Medicine; D005194:Family Practice; D006801:Humans; D010342:Patient Acceptance of Health Care; D010612:Pharyngitis / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy*; D010818:Practice Patterns, Physicians'; D012213:Rheumatic Fever / Q000382:microbiology; D013290:Streptococcal Infections / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy*; D013297:Streptococcus pyogenes
D000900:Anti-Bacterial Agents